{"entity":{"id":"jci","kind":"journal","name":"Journal of Clinical Investigation","aka":["JCI","J Clin Invest"],"tldr":"The Journal of Clinical Investigation is a century-old physician-scientist journal, free to read, publishing mechanistic disease biology including tumour immunology, metabolism and early CAR-T science.","summary":"Monthly and fully free to read, published by the non-profit American Society for Clinical Investigation. Publishes translational studies across medicine with a strong cancer immunology and haematology component, including early CAR-T and tumour-microenvironment work. JCI Insight is its open-access sister.","asOf":"2026-09-09","links":[{"label":"JCI Insight","url":"https://insight.jci.org"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["preclinical"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"American Society for Clinical Investigation","url":"https://www.jci.org","issn":"0021-9738","scope":"translational medicine","access":"open-access","founded":1924,"matchNames":["Journal of Clinical Investigation","JCI","J Clin Invest"],"society":"American Society for Clinical Investigation"},"route":"/journals/jci/","neighbours":{"term":[{"id":"preclinical","kind":"term","name":"Preclinical","route":"/terms/preclinical/"}],"paper":[{"id":"paper-makvandi-j-clin-invest","kind":"paper","name":"A PET imaging agent for evaluating PARP-1 expression in ovarian cancer","route":"/key-papers/paper-makvandi-j-clin-invest/"},{"id":"paper-cd19-all-leukemia-j-clin-invest-2016","kind":"paper","name":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","route":"/key-papers/paper-cd19-all-leukemia-j-clin-invest-2016/"},{"id":"paper-mateo-genomics-lethal-prostate-diagnosis-castration-resistance-jci-2020","kind":"paper","name":"Genomics of lethal prostate cancer at diagnosis and castration resistance","route":"/key-papers/paper-mateo-genomics-lethal-prostate-diagnosis-castration-resistance-jci-2020/"},{"id":"paper-lehmann-tnbc-subtypes-jci-2011","kind":"paper","name":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","route":"/key-papers/paper-lehmann-tnbc-subtypes-jci-2011/"},{"id":"paper-labrecque-mcrpc-phenotypes-jci-2019","kind":"paper","name":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","route":"/key-papers/paper-labrecque-mcrpc-phenotypes-jci-2019/"},{"id":"paper-navigate-j-clin-invest-2021","kind":"paper","name":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","route":"/key-papers/paper-navigate-j-clin-invest-2021/"},{"id":"paper-gruosso-tnbc-spatial-immune-microenvironments-jci-2019","kind":"paper","name":"Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers","route":"/key-papers/paper-gruosso-tnbc-spatial-immune-microenvironments-jci-2019/"},{"id":"paper-ashkenazi-j-clin-invest","kind":"paper","name":"Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions","route":"/key-papers/paper-ashkenazi-j-clin-invest/"}],"person":[{"id":"hans-peter-kiem","kind":"person","name":"Hans-Peter Kiem","route":"/people/hans-peter-kiem/"},{"id":"stanley-riddell","kind":"person","name":"Stanley R. Riddell","route":"/people/stanley-riddell/"},{"id":"yoram-weiss","kind":"person","name":"Yoram G. Weiss","route":"/people/yoram-weiss/"}]}}